Insider · CIK 0001302443
Rick E Winningham
ceoofficerdirector
Files at JAZZ (Jazz Pharmaceuticals plc), TBPH (Theravance Biopharma, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -1,382,272 | - | - | 228,750 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -151,875 | - | - | 76,875 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Shares | -76,875 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Sharesindirect: As Custodian | -23,400 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Ordinary Sharesindirect: By Trust | -92,567 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | DDisposition to issuer Share Option (Right to Buy)derivative | -515,000 | - | - | 0 | 18 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 9,480 | 40 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 9,466 | 40 d ago |
| Jun 23, 2025 | TBPH Theravance Biopharma, Inc. | GGift Ordinary Shares | -20,000 | $0.00 | $0 | 1,733,180 | Jun 25, 2025 |
| Jun 13, 2025 | TBPH Theravance Biopharma, Inc. | GGift Ordinary Shares | -9,600 | $0.00 | $0 | 1,753,180 | Jun 17, 2025 |
| Jun 13, 2025 | TBPH Theravance Biopharma, Inc. | GGift Ordinary Sharesindirect: As Custodian | +9,600 | $0.00 | $0 | 13,500 | Jun 17, 2025 |
| May 20, 2025 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -15,364 | $9.45 | $145k | 1,762,780 | May 22, 2025 |
| Nov 20, 2024 | TBPH Theravance Biopharma, Inc. | FTax withholding Ordinary Shares | -15,997 | $9.97 | $159k | 1,811,095 | Nov 22, 2024 |
| Nov 14, 2024 | TBPH Theravance Biopharma, Inc. | AGrant or award Ordinary Shares | +3,193 | $9.57 | $31k | 1,827,092 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.